Status:

UNKNOWN

Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)

Lead Sponsor:

Shahid Beheshti University of Medical Sciences

Conditions:

Proliferative Vitreoretinopathy

Eligibility:

MALE

18-65 years

Phase:

PHASE3

Brief Summary

To evaluate the efficacy of oral colchicine combined with intraoperative infusion of dexamethasone, low molecular weight heparin and 5-FU during vitrectomy for management of established proliferative ...

Eligibility Criteria

Inclusion

  • Cases with rhegmatogenous retinal detachment complicated by PVR grade C

Exclusion

  • History of pars plana vitrectomy for PVR grade C
  • History of silicone oil injection
  • History of ocular trauma
  • Diabetic retinopathy
  • Glaucoma
  • Giant retinal tear

Key Trial Info

Start Date :

September 1 2006

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00370760

Start Date

September 1 2006

Last Update

June 26 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hamid Ahmadieh, MD

Tehran, Tehran Province, Iran, 16666